Related Experiment Video
Updated: Jul 29, 2025
08:50
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
784
Biomaterial-enabled 3D cell culture technologies for extracellular vesicle manufacturing
James Johnston1, Trevor Stone1, Yichun Wang1
1Department of Chemical & Biomolecular Engineering, University of Notre Dame, 240C McCourtney Hall, Notre Dame, Indiana 46556, USA. ywang65@nd.edu.
Biomaterials Science
|May 24, 2023
Summary
Three-dimensional (3D) cell cultures enhance extracellular vesicle (EV) production for drug delivery. Biomaterial scaffolds improve EV yield and therapeutic efficacy, but scaling up 3D culture manufacturing remains a challenge for clinical translation.
Area of Science:
- Biomaterials and Regenerative Medicine
- Cell Biology and Therapeutics
- Drug Delivery Systems
Background:
- Extracellular vesicles (EVs) are lipid-based nanoparticles with therapeutic potential.
- Current EV manufacturing methods face challenges in clinical translation.
- Three-dimensional (3D) cell cultures offer a promising alternative for enhanced EV production.
Purpose of the Study:
- To review advances in biomaterial-enabled 3D cell cultures for EV manufacturing.
- To analyze the impact of 3D culture platforms on EV yield, quality, and therapeutic efficacy.
- To discuss challenges and opportunities for scaling up 3D EV production for industrial applications.
Main Methods:
- Review of current literature on biomaterial scaffolds in 3D cell culture for EV production.
- Analysis of studies reporting on EV yield, cargo content, and functional properties from 3D cultures.
- Discussion of scalability and industrial implementation challenges for 3D EV manufacturing platforms.
Main Results:
- 3D cell cultures significantly enhance EV yield and improve functional cargo loading compared to 2D methods.
- EVs derived from 3D cultures demonstrate superior therapeutic efficacy in preclinical models.
- Biomaterial properties can be tuned to optimize EV production characteristics.
Conclusions:
- Biomaterial-enabled 3D cell cultures represent a powerful strategy for improving therapeutic EV manufacturing.
- Further research and development are needed to overcome scalability challenges for industrial-scale production.
- Optimized 3D culture systems hold significant promise for advancing EV-based therapies.
